Receptor-interacting protein 140 mRNA expression in adipose tissue of a mouse model of high fat diet

doi:10.3969/j.issn.2095-4344.2014.18.018

Abstract

Abstract:

BACKGROUND: Receptor-interacting protein 140-knockout mice are lean and resistant to high fat diet-induced obesity due to an increase in mitochondrial biogenesis, fatty acid oxidation and oxidative phosphorylation.
OBJECTIVE: To study the expression level of receptor-interacting protein 140 mRNA in adipose tissue of high fat diet-induced obese mice and the correlation with insulin resistance.
METHODS: Male C57BL/6J mice were randomly divided into control group and high fat diet group, and fed for 14 weeks separately. The mice of the two groups were weighed. Mice in high fat diet group whose body weight were 20% higher than average weight of control mice were selected as obese mice.
RESULTS AND CONCLUSION: A total of 12 mice in high fat diet group were recruited into the obesity group. The levels of triglycerides, total cholesterol, fast blood glucose and fast insulin in obesity group were significantly higher than those of control group (P < 0.05 or P < 0.01). The expression of receptor-interacting protein 140 mRNA in adipose was significantly higher in obesity group compared with the controls (P < 0.05). Moreover, the expression of receptor-interacting protein 140 mRNA in adipose was positively correlated with triglycerides levels and insulin resistance index (r=0.526, P < 0.05; r=0.465, P < 0.05), but negatively associated with the levels of total cholesterol, fast blood glucose and fast insulin (P > 0.05).

中国组织工程研究杂志出版内容重点：肾移植；肝移植；移植；心脏移植；组织移植；皮肤移植；皮瓣移植；血管移植；器官移植；组织工程

全文链接：

Key words: insulin, obesity, subcutaneous fat, food habits

CLC Number:

R318

Zhai Yan-pan, Wang Luan, Ma Rui-xin. Receptor-interacting protein 140 mRNA expression in adipose tissue of a mouse model of high fat diet[J]. Chinese Journal of Tissue Engineering Research, 2014, 18(18): 2892-2896.

Figures/Tables 3

References

[1] Guyenet SJ, Schwartz MW. Clinical review: Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J Clin Endocrinol Metab. 2012;97(3):745-755.
[2] Sethi JK, Vidal-Puig AJ. Targeting fat to prevent diabetes. Cell Metab. 2007;5(5):323-325.
[3] Badman MK, Flier JS. The adipocyte as an active participant in energy balance and metabolism. Gastroenterology. 2007; 132(6):2103-2115.
[4] Ahima RS, Lazar MA. Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol. 2008; 22(5):1023-1031.
[5] Francis GA, Fayard E, Picard F, et al. Nuclear receptors and the control of metabolism. Annu Rev Physiol. 2003;65: 261-311.
[6] Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev. 2006;86(2):465-514.
[7] Feige JN, Auwerx J. Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 2007;17(6): 292-301.
[8] Herzog B, Hallberg M, Seth A, et al. The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. Mol Endocrinol. 2007;21(11):2687-2697.
[9] Rosell M, Jones MC, Parker MG. Role of nuclear receptor corepressor RIP140 in metabolic syndrome. Biochim Biophys Acta. 2011;1812(8):919-928.
[10] Hallberg M, Morganstein DL, Kiskinis E, et al. A functional interaction between RIP140 and PGC-1alpha regulates the expression of the lipid droplet protein CIDEA. Mol Cell Biol. 2008;28(22):6785-6795.
[11] Fritah A, Steel JH, Parker N, et al. Absence of RIP140 reveals a pathway regulating glut4-dependent glucose uptake in oxidative skeletal muscle through UCP1-mediated activation of AMPK. PLoS One. 2012;7(2):e32520.
[12] Powelka AM, Seth A, Virbasius JV, et al. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest. 2006;116(1):125-136.
[13] Ho PC, Lin YW, Tsui YC, et al. A negative regulatory pathway of GLUT4 trafficking in adipocyte: new function of RIP140 in the cytoplasm via AS160. Cell Metab. 2009;10(6):516-523.
[14] Ho PC, Wei LN. Biological activities of receptor-interacting protein 140 in adipocytes and metabolic diseases. Curr Diabetes Rev. 2012;8(6):452-457.
[15] Fritah A, Christian M, Parker MG. The metabolic coregulator RIP140: an update. Am J Physiol Endocrinol Metab. 2010; 299(3):E335-340.
[16] O'Rahilly S. Human obesity and insulin resistance: lessons from experiments of nature. Novartis Found Symp. 2007;286: 13-23, 162-3, 196-203.
[17] 陈蕾,贾伟平,项坤三,等.肥胖者胰岛素抵抗与总体脂、局部体脂关系的研究[J].中华内分泌代谢杂志,2001,17(5):276-279.
[18] 中华人民共和国科学技术部.关于善待实验动物的指导性意见. 2006-09-30.
[19] 杨爱君,崔雁,叶卉初,等.营养性肥胖动物模型的建立[J].临床和实验医学杂志,2005,4(3):156-157.
[20] 石国富,张洪德,王丽娟,等. ELISA检测胰岛素的进一步研究[J].标记免疫分析与临床,1996(4):234.
[21] Oliveira EP, Lima Md, Souza ML. Metabolic syndrome, its phenotypes, and insulin resistance by HOMA-IR. Arq Bras Endocrinol Metabol. 2007;51(9):1506-1515.
[22] Duncan MH, Singh BM, Wise PH, et al. A simple measure of insulin resistance. Lancet. 1995;346(8967):120-121.
[23] 张宏山,许明,张阳,等.小鼠心肌组织3种总RNA提取方法比较[J].临床心血管病杂志,2010,26(2):149-150.
[24] 高海,李燕,周变华,等.动物脂肪代谢与肥胖基因调节研究进展[J].动物医学进展,2007,28(12):99-101.
[25] Fortuño A, Rodríguez A, Gómez-Ambrosi J, et al. Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem. 2003;59(1):51-60.
[26] Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-846.
[27] Calle EE. Obesity and cancer. BMJ. 2007;335(7630): 1107-1108.
[28] Stefan N, Häring HU, Hu FB, et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1(2):152-162.
[29] Cavaillès V, Dauvois S, L'Horset F, et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 1995;14(15):3741-3751.
[30] Lee CH, Chinpaisal C, Wei LN. Cloning and characterization of mouse RIP140, a corepressor for nuclear orphan receptor TR2. Mol Cell Biol. 1998;18(11):6745-6755.
[31] Chen WH. Turning down the heat: the potential role of RIP140 in inflammation. Cell Mol Immunol. 2012;9(3):195-196.
[32] Leonardsson G, Steel JH, Christian M, et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci U S A. 2004;101(22):8437-8442.
[33] Christian M, Kiskinis E, Debevec D, et al. RIP140-targeted repression of gene expression in adipocytes. Mol Cell Biol. 2005;25(21):9383-9391.
[34] 查锡良.生物化学[M].7版.北京:人民卫生出版社,2008.
[35] 李光伟,李春梅,孙淑湘,等.胰岛素抵抗--遗传和环境因素致高血压的共同途径?[J].中华内科杂志,2003,42(1):11-15.
[36] 周鹏,陈南衡,王其民.高甘油三酯血症与胰岛素抵抗及糖代谢异常的关系[J].中华内科杂志,1998,37(7):447-450.
[37] 窦梅,马爱国.胰岛素抵抗主要原因及机制的研究进展[J].国外医学卫生学分册,2009,36(3):175-179.
[38] 李伶,杨刚毅.脂代谢紊乱和脂肪细胞因子与胰岛素抵抗[J].中国糖尿病杂志,2007,15(3):129-131.
[39] Kamon J, Yamauchi T, Terauchi Y, et al. The mechanisms by which PPARgamma and adiponectin regulate glucose and lipid metabolism. Nihon Yakurigaku Zasshi. 2003;122(4): 294-300.
[40] Yano W, Kubota N, Itoh S, et al. Molecular mechanism of moderate insulin resistance in adiponectin-knockout mice. Endocr J. 2008;55(3):515-522.
[41] Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8(11):1288-1295.
[42] Gupta P, Ho PC, Huq MD, et al. PKCepsilon stimulated arginine methylation of RIP140 for its nuclear-cytoplasmic export in adipocyte differentiation. PLoS One. 2008;3(7): e2658.
[43] Christian M, White R, Parker MG. Metabolic regulation by the nuclear receptor corepressor RIP140. Trends Endocrinol Metab. 2006;17(6):243-250.
[44] White R, Morganstein D, Christian M, et al. Role of RIP140 in metabolic tissues: connections to disease. FEBS Lett. 2008; 582(1):39-45.